Warning: The NCBI web site requires JavaScript to function. more...
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium.
Dharmapatni AA, Smith MD, Findlay DM, Holding CA, Evdokiou A, Ahern MJ, Weedon H, Chen P, Screaton G, Xu XN, Haynes DR.
Arthritis Res Ther. 2009;11(1):R13. Epub 2009 Jan 27.
Related citations
Inhibition of apoptosis in periodontitis.
Lucas H, Bartold PM, Dharmapatni AA, Holding CA, Haynes DR.
J Dent Res. 2010 Jan;89(1):29-33. Epub .
Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
Perlman H, Nguyen N, Liu H, Eslick J, Esser S, Walsh K, Moore TL, Pope RM.
Arthritis Rheum. 2003 Nov;48(11):3096-101.
Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Park YW, Ji JD, Lee JS, Ryang DW, Yoo DH.
Scand J Rheumatol. 2003;32(6):356-63.
Importance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cells.
Yamasaki S, Kawakami A, Nakashima T, Nakamura H, Kamachi M, Honda S, Hirai Y, Hida A, Ida H, Migita K, Kawabe Y, Koji T, Furuichi I, Aoyagi T, Eguchi K.
Ann Rheum Dis. 2001 Jul;60(7):678-84.
Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent.
Pundt N, Peters MA, Wunrau C, Strietholt S, Fehrmann C, Neugebauer K, Seyfert C, van Valen F, Pap T, Meinecke I.
Arthritis Res Ther. 2009;11(1):R16. Epub 2009 Feb 5.
COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
Int J Mol Med. 2006 Jul;18(1):41-7.
TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis.
Ichikawa K, Liu W, Fleck M, Zhang H, Zhao L, Ohtsuka T, Wang Z, Liu D, Mountz JD, Ohtsuki M, Koopman WJ, Kimberly R, Zhou T.
J Immunol. 2003 Jul 15;171(2):1061-9.
A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
Sasaki H, Ohara N, Xu Q, Wang J, DeManno DA, Chwalisz K, Yoshida S, Maruo T.
J Clin Endocrinol Metab. 2007 Feb;92(2):616-23. Epub 2006 Nov 14.
Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
van Lent PL, Span PN, Sloetjes AW, Radstake TR, van Lieshout AW, Heuvel JJ, Sweep CG, van den Berg WB.
Ann Rheum Dis. 2005 Mar;64(3):368-74. Epub 2004 Oct 14.
Rheumatoid arthritis synovial fluid fibroblasts express TRAIL-R2 (DR5) that is functionally active.
Miranda-Carús ME, Balsa A, Benito-Miguel M, De Ayala CP, Martín-Mola E.
Arthritis Rheum. 2004 Sep;50(9):2786-93.
Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells (FLS) by phosphorylation of Akt.
Fujikawa K, Kawakami A, Tanaka F, Iwamoto N, Tamai M, Eguchi K.
Clin Exp Rheumatol. 2009 Nov-Dec;27(6):952-7.
Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, Choi KS.
Oncogene. 2005 Oct 20;24(46):6877-89.
Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.
Terzioglu E, Bisgin A, Sanlioglu AD, Ulker M, Yazisiz V, Tuzuner S, Sanlioglu S.
Rheumatology (Oxford). 2007 May;46(5):783-9. Epub 2007 Feb 19.
Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
Kumamoto H, Ooya K.
J Oral Pathol Med. 2005 May;34(5):287-94.
The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
Pierer M, Brentano F, Rethage J, Wagner U, Hantzschel H, Gay RE, Gay S, Kyburz D.
Rheumatology (Oxford). 2007 Jul;46(7):1063-70. Epub 2007 Apr 10.
Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S, Miura Y, Nishiyama T, Mitani M, Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S, Doita M.
Arthritis Rheum. 2007 Apr;56(4):1067-75.
Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis.
Jüngel A, Baresova V, Ospelt C, Simmen BR, Michel BA, Gay RE, Gay S, Seemayer CA, Neidhart M.
Ann Rheum Dis. 2006 Jul;65(7):910-2. Epub 2005 Nov 10.
In chronic pancreatitis, widespread emergence of TRAIL receptors in epithelia coincides with neoexpression of TRAIL by pancreatic stellate cells of early fibrotic areas.
Hasel C, Dürr S, Rau B, Sträter J, Schmid RM, Walczak H, Bachem MG, Möller P.
Lab Invest. 2003 Jun;83(6):825-36.
Urocortin in the synovial tissue of patients with rheumatoid arthritis.
Uzuki M, Sasano H, Muramatsu Y, Totsune K, Takahashi K, Oki Y, Iino K, Sawai T.
Clin Sci (Lond). 2001 Jun;100(6):577-89.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on